Position in AMGN
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$1,338,245,590
+$3,522,682 QoQ
Shares Held
3,695,586
-2.6% QoQ
Ownership
0.684%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
#22
of 3,131 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 90%
Shared 0%
None 10%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Bank of New York Mellon Corp holds $24,361,895,957 across 16 Drug Manufacturers - General names. AMGN ranks #7 (5.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,783,459 | $5,737,424,695 | |
| 2 | JNJ |
Johnson & Johnson
|
21,683,347 | $5,506,919,623 | |
| 3 | ABBV |
AbbVie Inc.
|
12,853,368 | $3,234,421,512 | |
| 4 | MRK |
Merck & Co., Inc.
|
18,340,173 | $2,356,712,224 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
15,263,929 | $1,928,444,775 | |
| 6 | PFE |
Pfizer Inc
|
57,879,546 | $1,393,739,453 | |
| 7 | AMGN |
Amgen Inc
This page
|
3,695,586 | $1,338,245,590 | |
| 8 | AZN |
Astrazeneca PLC
|
6,753,962 | $1,280,686,266 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,338,245,590 | 3,695,586 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $1,334,722,908 | 3,793,443 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $1,278,805,396 | 3,907,016 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $1,122,926,282 | 3,979,186 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $1,117,818,344 | 4,003,504 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $1,386,427,710 | 4,450,097 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $1,194,034,837 | 4,581,165 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $1,669,297,502 | 5,180,775 | Shares | Other | 2024-11-12 | |
| 2024-06-30 | $1,675,860,247 | 5,363,611 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $1,523,671,724 | 5,359,003 | Shares | Other | 2024-04-25 | |
| 2023-12-31 | $1,581,907,501 | 5,492,353 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $1,461,297,028 | 5,437,182 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $1,193,502,693 | 5,375,654 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $1,309,013,388 | 5,414,740 | Shares | Other | 2023-05-09 | |
| 2022-12-31 | $1,448,397,348 | 5,514,763 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,345,534,989 | 5,969,543 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,455,157,343 | 5,980,918 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $1,457,005,394 | 6,025,165 | Shares | Other | 2022-05-11 | |
| 2021-12-31 | $1,418,602,320 | 6,305,740 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $1,269,663,392 | 5,970,672 | Shares | Defined | 2021-11-18 | |
| 2021-06-30 | $1,458,105,671 | 5,981,972 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $1,591,317,095 | 6,395,712 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $1,498,202,166 | 6,516,189 | Shares | Other | 2021-02-09 | |
| 2020-09-30 | $1,744,013,636 | 6,861,873 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $1,576,311,340 | 6,683,250 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $1,320,044,763 | 6,511,344 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||